Christopher R. Christensen sold $5.8M of ENSG
Executive Chairman at ENSIGN GROUP, INC. 39,086 shares at an average of $148.52, traded Feb 5, 2025, filed Feb 5, 2025.
Score components
- +20RoleChair
- +25Trade size$5.8M at market
- +20Share of holdings soldSold 76% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -12.4%, 3m -8.0%, 6m +6.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001125376-25-000025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +3,539 | $15.80 | $56k | 16,078 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +23,597 | $45.34 | $1.1M | 39,675 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +4,000 | $44.84 | $179k | 43,675 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +3,750 | $82.20 | $308k | 47,425 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +2,800 | $80.60 | $226k | 50,225 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +1,400 | $90.85 | $127k | 51,625 | Feb 5, 2025 |
| Feb 5, 2025 | SOpen-market sale Common Stock10b5-1 | -35,694 | $148.47 | $5.3M | 15,931 | Feb 5, 2025 |
| Feb 5, 2025 | SOpen-market sale Common Stock10b5-1 | -3,392 | $149.09 | $506k | 12,539 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -3,539 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -23,597 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -4,000 | $0.00 | $0 | 1,000 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -3,750 | $0.00 | $0 | 2,500 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -2,800 | $0.00 | $0 | 4,200 | Feb 5, 2025 |
| Feb 5, 2025 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,400 | $0.00 | $0 | 5,600 | Feb 5, 2025 |
Related signals
Other insiders at ENSIGN GROUP, INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | ENSIGN GROUP, INC | Ann Scott Blouin director | $69k 375 shares | -2% | |
| 18Weak | ENSIGN GROUP, INC | John O Agwunobi director | $67k 392 shares | -4% | |
| 10Weak | ENSIGN GROUP, INC | Mark Vincent Parkinson director | $17k 100 shares | -3% | |
| 5Weak | ENSIGN GROUP, INC | Barry M Smith director | $115k 700 shares | -3% | |
| 14Weak | ENSIGN GROUP, INC | Barry M Smith director | $128k 700 shares | -3% | |
| 19Weak | ENSIGN GROUP, INC | John O Agwunobi director | $78k 392 shares | -4% | |
| 10Weak | ENSIGN GROUP, INC | Mark Vincent Parkinson director | $20k 100 shares | -3% | |
| 14Weak | ENSIGN GROUP, INC | Barry M Smith director | $138k 700 shares | -3% | |
| 21Weak | ENSIGN GROUP, INC | Barry M Smith director | $149k 700 shares | -3% | |
| 5Weak | ENSIGN GROUP, INC | Beverly B. Wittekind VP and Chief Legal Officer | $105k 500 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.